Banks’ blockchain consortium picks IBM for trade finance platform
June 27, 2017
Apple CEO touts India impact in push for deeper market access
June 27, 2017

‘Pharma bro’ Martin Shkreli heads into fraud trial

NEW YORK (Reuters) – Martin Shkreli, the pharmaceutical entrepreneur vilified as the “pharma bro” for raising the price of a life-saving drug by 5,000 percent, will go on trial on Monday for what U.S. prosecutors called a Ponzi-like scheme at his former hedge fund and a drug company he once ran.

Powered by WPeMatico